A dual-modal GSH depletion and NIR-triggered nanoplatform for cascade-amplified phototherapy
Colloids and Surfaces B: Biointerfaces · 2026
DOI: 10.1016/j.colsurfb.2026.115461 ↗Kurz gefasst
Fachartikel in der Zeitschrift Colloids and Surfaces B: Biointerfaces, 2026. Verfasst von Shuang Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Xuzhou Medical University, Xuzhou 221004, PR China; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Med…. Hauptthemen laut MEDLINE: Glutathione, Nanoparticles, Photochemotherapy, Photosensitizing Agents. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China, Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy.
Abstract (Originalsprache)
In tumor phototherapy, the intracellular antioxidant defenses, such as high concentrations of glutathione (GSH) and inefficient generation of reactive oxygen species (ROS) significantly restrict the therapeutic efficacy. In this research, we construct a dual-modal GSH depletion and near-infrared (NIR)-triggered nanoplatform (Ce6@CDP) for cascade-amplified photothermal therapy (PTT) and photodynamic therapy (PDT). This nanoplatform featured a hollow mesoporous copper sulfide (CuS) core loaded with Ce6 and encapsulated by a disulfide bond-containing polymer (DS-ANPA-PEG). Upon tumor accumulation, the polymer DS-ANPA-PEG reacts with intracellular GSH to form highly reactive quinone methides (QMs), enabling rapid GSH depletion through alkylation. This dual GSH depletion intensifies oxidative stress, potentiating Ce6-based PDT efficacy. Additionally, the CuS carrier exhibits high photothermal conversion performance (η = 39.68 %), enabling PTT under 808 nm laser irradiation for synergistic tumor eradication. Both in vitro and in vivo studies demonstrate that the PDT/PTT combination therapy significantly inhibits tumor growth while maintaining negligible systemic toxicity. Our findings provide a rational design strategy for developing tumor-microenvironment-responsive multimodal nanoplatforms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Xuzhou Medical University, Xuzhou 221004, PR China; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221004, PR China.
- School of Medical Imaging, Xuzhou Medical University, Xuzhou 221004, PR China.
- School of Medical Imaging, Xuzhou Medical University, Xuzhou 221004, PR China. Electronic address: minghuiai@xzhmu.edu.cn.
- Xuzhou Central Hospital, Xuzhou 221009, PR China; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221004, PR China. Electronic address: wangdan1835324738@163.com.
- School of Pharmacy, Xuzhou Medical University, Xuzhou 221004, PR China; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou 221004, PR China. Electronic address: chengguo…
Förderung
- Natural Science Foundation of Jiangsu Province
- National Natural Science Foundation of China
- Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy
Zitieren
APA
Liu, S., Chen, X., Liu, X., Zhang, H., Zhou, K., Shan, Y., Chen, M., Wang, D., & Cheng, G. (2026). A dual-modal GSH depletion and NIR-triggered nanoplatform for cascade-amplified phototherapy. Colloids and Surfaces B: Biointerfaces. https://doi.org/10.1016/j.colsurfb.2026.115461
Vancouver
Liu S, Chen X, Liu X, Zhang H, Zhou K, Shan Y, et al. A dual-modal GSH depletion and NIR-triggered nanoplatform for cascade-amplified phototherapy. Colloids and Surfaces B: Biointerfaces. 2026. doi:10.1016/j.colsurfb.2026.115461
BibTeX
@article{Liu2026,
author = {Liu, Shuang and Chen, Xingyu and Liu, Xiaojin and Zhang, Hao and Zhou, Keyue and Shan, Yuting and Chen, Minghui and Wang, Dan and Cheng, Guohui},
title = {A dual-modal GSH depletion and NIR-triggered nanoplatform for cascade-amplified phototherapy},
journal = {Colloids and Surfaces B: Biointerfaces},
year = {2026},
doi = {10.1016/j.colsurfb.2026.115461}
}
EUVIMED